Comparison of Presenting Features and Three-year Disease Course in Turkish Patients with Behçet Uveitis Who Presented in the Early 1990s and the Early 2000s

Purpose: To compare Behçet uveitis patients who presented in the 1990s and 2000s. Methods: Records of 170 patients seen in 1990–1994 and 258 patients seen in 2000–2004 were reviewed. Presenting features were analyzed in the whole cohort. Uveitis attacks, vision, complications, and immunomodulatory treatment (IMT) were compared in patients with 3-year follow-up. Results: Posterior segment involvement was less common, visual acuity was better, and more patients received IMT before referral in the 2000s. Follow-up revealed no significant difference in number of uveitis attacks in the first 3 years. Less eyes lost useful vision, no patient became legally blind, and fewer severe ocular complications occurred in the 2000s. IMT was started within 3 months in more patients and interferon alfa-2a was used only in the latter study period. Conclusions: The findings suggest a milder disease at referral, lower rate of severe complications, and a better 3-year visual outcome in patients who presented in the early 2000s.

[1]  D. Wakefield,et al.  Behçet disease: visual prognosis and factors influencing the development of visual loss. , 2011, American journal of ophthalmology.

[2]  Mitsuko Takamoto,et al.  Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet’s disease , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  S. Ohno,et al.  Clinical features of intraocular inflammation in Hokkaido, Japan , 2009, Acta ophthalmologica.

[4]  H. Yu,et al.  Fluorescein Angiography and Visual Acuity in Active Uveitis with Behçet Disease , 2009, Ocular immunology and inflammation.

[5]  M. Khairallah,et al.  Pattern of uveitis in Behçet’s disease in a referral center in Tunisia, North Africa , 2009, International Ophthalmology.

[6]  C. Zouboulis,et al.  Ocular involvement in Adamantiades-Behçet’s disease in Berlin, Germany , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[7]  J. Kempen,et al.  Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. , 2008, American journal of ophthalmology.

[8]  R. Nussenblatt,et al.  Behçet's disease: comparing 3 decades of treatment response at the National Eye Institute. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[9]  Q. Meng,et al.  Clinical features of chinese patients with Behçet's disease. , 2008, Ophthalmology.

[10]  Y. Akova,et al.  Demographic and Clinical Features of Uveitis in Tertiary Centers in Turkey , 2008, Ophthalmic epidemiology.

[11]  H. Dua,et al.  OCULAR FEATURES OF BEHÇET’S DISEASE: AN INTERNATIONAL COLLABORATIVE STUDY , 2007 .

[12]  İ. Tuğal-Tutkun,et al.  Results of interferon-alfa therapy in patients with Behçet uveitis , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  H. Goto,et al.  Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[14]  T. Kaburaki,et al.  Statistical Analysis of Endogenous Uveitis at Tokyo University Hospital (1998–2000) , 2005, Japanese Journal of Ophthalmology.

[15]  İ. Tuğal-Tutkun,et al.  Uveitis in Behçet disease: an analysis of 880 patients. , 2004, American journal of ophthalmology.

[16]  M. Araie,et al.  Comparison of patients with Behçet's disease in the 1980s and 1990s. , 2004, Ophthalmology.

[17]  S. Kotake,et al.  Characteristics of endogenous uveitis in Hokkaido, Japan , 1996, Graefe's Archive for Clinical and Experimental Ophthalmology.

[18]  A. Okada,et al.  Changing patterns of intraocular inflammatory disease in Japan , 2003, Ocular immunology and inflammation.

[19]  F. Shahram,et al.  Recent epidemiological data on Behçet's disease in Iran. The 2001 survey. , 2003, Advances in experimental medicine and biology.

[20]  F. Spertini,et al.  Behçet’s disease in Western Switzerland: Epidemiology and analysis of ocular involvement , 2002, Ocular immunology and inflammation.

[21]  M. Mochizuki,et al.  Behçet's disease in Japan and in Great Britain: a comparative study. , 2000, Ocular immunology and inflammation.

[22]  K. Masuda,et al.  Epidemiological features and visual prognosis of Behçet's disease. , 1999, Japanese journal of ophthalmology.

[23]  S. Dündar,et al.  Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey. , 1997, Ophthalmology.

[24]  Ts'ai Hy,et al.  [Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments]. , 1990 .

[25]  Y. M. Chung,et al.  [Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments]. , 1990, Journal of the Formosan Medical Association = Taiwan yi zhi.

[26]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.

[27]  H. Behcet UBER REZIDIVERENDE APHTHOSE DURCH EIN VIRUS VERURSACHTE GESCHWURE AM MUND, AM AUGE UND AN DEN GENITALIEN , 1937 .